Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis

NCT02425644 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1133

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: ponesimod
DRUG: teriflunomide

Sponsor

Actelion